Denise Neves Gameiro, Author at Labiotech.eu

About

Journalist intern. Studied Bioengineering in Porto and was a lab rat in Sweden. Enjoying Berlin and the company of Labiotech’s resident plants.

Articles by Denise Neves Gameiro

diabaetes insulin biotech islexa catapult uk trials aberdeen

News and Trends 18 May 2016

New UK Biotech could treat Diabetes with Lab-grown Cells

Islexa is the new baby of Catapult and the University of Aberdeen, which will be developing laboratory grown islets. This could replace insulin production in patients with type 1 diabetes. One of the coolest Biotechs in London, Catapult has joined the University of Aberdeen to create a new Biotech that could revolutionize treatment of type […]

May 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

imab ganymed gastroesophegal cancer asco

News and Trends 17 May 2016

‘Ideal’ German Antibodies have promising data for Gastro Cancer

Ganymed is presenting promising results of its phase II trial in gastroesophageal cancer at the ASCO Annual meeting 2016 in Chicago, one of the leading Oncology conferences worldwide. Based in Mainz (Germany), Ganymed is a Biopharma developing immunotherapies to tackle cancer, having joined forces with BioNTech (Germany’s larget private Biotech) 2 years ago to create […]

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

sobi hemophilia clotting factor alprolix

News and Trends 17 May 2016

Rare Disease Biopharma can now sell Hemophilia treatment across whole of EU

Sobi has received market approval by the European Comission for Alprolix, a long-duration protein therapy that protects hemophilia B patients from uncontrolled bleeding. With a focus on rare diseases, Swedish Orphan Biovitrum (Sobi) has clinical programmes in diseases like alkaptonuria, tyrosinaemia and hemophilia – a disease with which Sobi is particularly invested. Its candidate for hemophilia […]

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 17 May 2016

New Italian Drug is FDA approved for trials in Rare Neurological Disease

Newron sees its Investigational New Drug application approved by the FDA. It can now begin clinical trials for Rett Syndrome patients – a rare neurological disorder. Based near Milan (Italy), Newron is a Biopharma developing therapies for diseases of the central nervous system (CNS). Last year it raised over €23M to advance its pipeline, which features candidates […]

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

dresden spermbot sperm nanotechnology biotech IFW

News and Trends 12 May 2016

Sperm Cells Enlisted as Nanobot Delivery Guys

Reserchears at IFW Dresden were trying to create a nanorobot for drug delivery and even gene manipulation. They ended up using one of the motors created by nature – the flagella of sperm cells. Drug delivery is a key part in the development of new drugs, and an active field of research with academy-industry partnerships. Examples of ideas […]

May 12, 2016 - 3 minutesmins - By Denise Neves Gameiro

oxstem regenerative medicine stem cell leukemia

News and Trends 12 May 2016

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

OxStem’s strategy for stem cells therapy inside the body could have a big impact in regenerative medicine – and it has raised €21.4M, a record for a UK spin-out. A spin-out of Oxford University, OxStem is developing cell programming therapies that could treat a range of usually age-related conditions – dementia, heart failure, macular degeneration, […]

May 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

technical university munich tum catalysis synbio

News and Trends 11 May 2016

Artificial enzymes to be developed in Munich with new Synbio Programme

Biological systems that could produce insulin out of greenhouse gas – this is one of the goals of the new €11.5M Synthetic Biology programme, at the Technical University of Munich (TUM). The Technical University of Munich (TUM) has many research highlights, including CAR-T research with impressive results. It has recently created the TUM School of Bioengineering […]

May 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 11 May 2016

German mRNA specialist moves into Animal Health in collaboration with Bayer

BioNTech is joining its mRNA technology with Bayer’s expertise in veterinary applications in a new collaboration – to develop first-in-class vaccines for animals. Based in Mainz (Germany), BioNTech is the largest private Biotech in Europe. Along with its CAR-T and TCR programmes, BioNTech is developing mRNA therapies – a promising field in medicine. These include immunotherapies for […]

May 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 10 May 2016

Life Sciences VC gets €204M in its Biggest Fundraiser Ever

MVM Capital has raised its fourth and largest funding round. It now has an additional €204M to invest in healthcare in the US and Europe. With offices in Boston and London, MVM Capital is an important VC in the healthcare sector – from biotechnology to medical devices. Its biggest success story is perhaps Heptares, a […]

May 10, 2016 - 2 minutesmins - By Denise Neves Gameiro

bristol ieropoulos microbial fuel cell mfc urine

News and Trends 10 May 2016

British Researchers Stack Bacteria to Turn Urine into Electricity

Researchers from Bristol in the UK developed a new design of microbial fuel cells (MFCs), a more efficient way to use wastewater to produce electricity. Want to power your smartphone with your pee? Biotechnology has been diligently working on the idea for decades now, with microbial fuel cells (MFCs). A fuel cell is a technology that can […]

May 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

novigenix colox clinical cancer research

News and Trends 9 May 2016

Swiss Blood Test for colorectal cancer joins race of ‘Liquid Biopsies’

Novigenix has published a validation study of its molecular blood test (Colox) which can reliably detect colorectal cancer at an early stage. Is this the second-place diagnostic in the race for Colorectal cancer blood tests? Based in Lausanne (Switzerland), Novigenix is developing molecular diagnostics from a new generation of predictive gene expression profiles and tumor-derived protein markers (biomarkers). Novigenix first […]

May 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

allergy therapeutics birch pollen rhinitis biotech uk

News and Trends 9 May 2016

UK Biopharma joins Allergy race with good Phase II results for Hayfever

Allergy Therapeutics has gotten positive results for its phase II trial for birch pollen allergy – another win for their Pollinex platform. Based near Brighton (UK), Allergy Therapeutics has around 420 employees and has a market cap of €1.96M (£1.53M). Its focus is novel immunotherapies, with new technology for improving delivery and adjuvants – agents […]

May 9, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Denise Neves Gameiro

About

Articles by Denise Neves Gameiro

New UK Biotech could treat Diabetes with Lab-grown Cells

‘Ideal’ German Antibodies have promising data for Gastro Cancer

Rare Disease Biopharma can now sell Hemophilia treatment across whole of EU

New Italian Drug is FDA approved for trials in Rare Neurological Disease

Sperm Cells Enlisted as Nanobot Delivery Guys

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

Artificial enzymes to be developed in Munich with new Synbio Programme

German mRNA specialist moves into Animal Health in collaboration with Bayer

Life Sciences VC gets €204M in its Biggest Fundraiser Ever

British Researchers Stack Bacteria to Turn Urine into Electricity

Swiss Blood Test for colorectal cancer joins race of ‘Liquid Biopsies’

UK Biopharma joins Allergy race with good Phase II results for Hayfever

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Denise Neves Gameiro

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!